Oncolytics Biotech faces Nasdaq delisting over share price
SAN DIEGO and CALGARY, AB - Oncolytics Biotech Inc. (NASDAQ: NASDAQ:ONCY) (TSX: ONC), a biotechnology firm focused on immunotherapy for cancer, has received a notification from the Nasdaq regarding ...
The Pharma Letter19h
InflaRx raises $30 million in public offering
Jena-based German biotech InflaRx has announced the pricing of an underwritten public offering, raising approximately $30 ...
'How can CJI pick CBI director?': Jagdeep Dhankhar sparks debate on executive appointments
BHOPAL: Vice President Jagdeep Dhankhar questioned on Friday the involvement of the Chief Justice of India (CJI) in any ...